Search results
Showing 316 to 330 of 883 results for community guidance
Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)
Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection
Generalised anxiety disorder and panic disorder in adults: management (CG113)
This guideline covers the care and treatment of people aged 18 and over with generalised anxiety disorder (chronic anxiety) or panic disorder (with or without agoraphobia or panic attacks). It aims to help people achieve complete relief of symptoms (remission), which is associated with better functioning and a lower likelihood of relapse.
In development Reference number: GID-TA11635 Expected publication date: 26 August 2026
In development Reference number: GID-TA11636 Expected publication date: 26 August 2026
In development Reference number: GID-TA11559 Expected publication date: 10 June 2026
Resmetirom for treating non-alcoholic steatohepatitis and liver fibrosis [ID6529]
In development Reference number: GID-TA11414 Expected publication date: 10 June 2026
In development Reference number: GID-TA11776 Expected publication date: TBC
Awaiting development Reference number: GID-TA11978 Expected publication date: TBC
In a virtual ward setting, you make assessments at home to support clinical decision-making. Our guidance can help you give advice by highlighting areas to consider and standards of care.
In development Reference number: GID-TA11566 Expected publication date: 10 June 2026
In development Reference number: GID-TA11477 Expected publication date: TBC
YOURmeds for medication support in long-term conditions (MIB289)
NICE has developed a medtech innovation briefing (MIB) on YOURmeds for medication support in long-term conditions .
In development Reference number: GID-TA11340 Expected publication date: TBC
Self-harm: assessment, management and preventing recurrence (NG225)
This guideline covers assessment, management and preventing recurrence for children, young people and adults who have self-harmed. It includes those with a mental health problem, neurodevelopmental disorder or learning disability and applies to all sectors that work with people who have self-harmed.
Training and development opportunities at NICE